The DOI matches its Crossref record.
THE ROLE OF ANTI-HLA ANTIBODIES IN HEART TRANSPLANTATION
Abstract
The major threat to long-term survival of heart allograft recipients is the development of graft atherosclerosis, which seems to be a manifestation of chronic rejection. To assess the role of anti-HLA antibodies in heart allograft rejection we studied 107 patients and compared the survival of recipients who formed anti-HLA antibodies with the survival of recipients who developed no antibodies. At 4 years the actuarial survival was 90% in the nonproducer group and 38% in antibody-producers (P = 0.038). We further explored the possibility that HLA antigens from the injured graft are released into the circulation and can be found in the serum either free or complexed with anti-HLA antibodies. This hypothesis was confirmed by the finding that the frequency of sera containing soluble HLA antigens from the graft or immune complexes of HLA alloantigens with anti-HLA antibodies was significantly higher in patients who rejected compared with patients with successful heart allografts (P less than 0.05). Following depletion of soluble HLA antigens, anti-HLA antibodies became detectable in 53% and 74% sera obtained during the first and second year posttransplantation, respectively, from patients undergoing chronic rejection. Long-term survivors showed a significantly lower (P less than 0.001) frequency of anti-HLA antibodies in sera depleted of HLA antigens. Lastly, studies of anti-anti-HLA-A2 and A3 antibodies in recipient sera suggest that quiescence is maintained by antiidiotypic antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Humoral Theory of Transplantation
Terasaki, P. I. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00135.x · Cited by 609
Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial
Terasaki, P. I., & Ozawa, M. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00360.x · Cited by 453
ANTI-HLA ANTIBODIES AFTER SOLID ORGAN TRANSPLANTATION1
McKenna, R. M., Takemoto, S. K., & Terasaki, P. I. (2000) · Transplantation · doi:10.1097/00007890-200002150-00001 · Cited by 382
Report from a consensus conference on antibody-mediated rejection in heart transplantation
Kobashigawa, J., Crespo-Leiro, M. G., Ensminger, S. M., Reichenspurner, H., Angelini, A., Berry, G., Burke, M., Czer, L., Hiemann, N., Kfoury, A. G., et al. (2011) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.11.003 · Cited by 368
Self-citationCiurea, S. O., de Lima, M., Cano, P., Korbling, M., Giralt, S., Shpall, E. J., Wang, X., Thall, P. F., Champlin, R. E., & Fernandez-Vina, M. (2009) · Transplantation · doi:10.1097/tp.0b013e3181b9d710 · Cited by 287
Metadata
- Authors
- SUCIU-FOCA, N., REED, E., MARBOE, C., HARRIS, P., XI, Y. P., YU-KAI, S., HO, E., ROSE, E., REEMTSMA, K., & KING, D. W.
- Venue
- TRANSPLANTATION
- Published
- 1991-03
- Volume
- 51
- Issue
- 3
- Pages
- 716-724
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2043263636
- Cited by
- 200
- References
- 0
- FWCI
- 11.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: THE ROLE OF ANTI-HLA ANTIBODIES IN HEART TRANSPLANTATION. https://app.cochat.ai/papers/10.1097/00007890-199103000-00033
- The paper
- SUCIU-FOCA, N., REED, E., MARBOE, C., HARRIS, P., XI, Y. P., YU-KAI, S., HO, E., ROSE, E., REEMTSMA, K., & KING, D. W. (1991). THE ROLE OF ANTI-HLA ANTIBODIES IN HEART TRANSPLANTATION. TRANSPLANTATION. https://doi.org/10.1097/00007890-199103000-00033
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.